T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIMC
501
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| – | – |
0
| – | – |
|
502
United Airlines
UAL
$41B
| $97.1M | 0.02% |
2,574,365
+36,304
| +1% | +$1.47M |
|
503
BioMarin Pharmaceuticals
BMRN
$13.3B
| $96M | 0.02% |
927,836
+316,129
| +52% | +$29.7M |
|
504
Gen Digital
GEN
$17.7B
| $95.1M | 0.02% |
4,438,619
+76,526
| +2% | +$1.69M |
|
505
Madison Square Garden
MSGS
$9.94B
| $94.8M | 0.02% |
517,097
+314
| +0.1% | +$49.3K |
|
506
LPL Financial
LPLA
$29.5B
| $94.1M | 0.02% |
435,371
+147,098
| +51% | +$34.4M |
|
507
Etsy
ETSY
$7.4B
| $93.8M | 0.02% |
783,477
-380,424
| -33% | -$43.5M |
|
508
Halozyme
HALO
$11.4B
| $93.2M | 0.02% |
1,637,959
+22,939
| +1% | +$1.17M |
|
|
CTLT
509
DELISTED
CATALENT, INC.
CTLT
| $92.6M | 0.01% |
2,056,807
+124,115
| +6% | +$6.75M |
|
510
Target
TGT
$70.6B
| $91.6M | 0.01% |
614,610
+2,716
| +0.4% | +$426K |
|
|
SIVB
511
DELISTED
SVB Financial Group
SIVB
| $91M | 0.01% |
395,401
+44,959
| +13% | +$11.2M |
|
512
MarketAxess Holdings
MKTX
$5.72B
| $90.8M | 0.01% |
325,702
-10,608
| -3% | -$2.73M |
|
513
Baker Hughes
BKR
$63B
| $90.6M | 0.01% |
3,066,534
+37,398
| +1% | +$1.03M |
|
514
Casella Waste Systems
CWST
$5.79B
| $90.5M | 0.01% |
1,141,452
-60,399
| -5% | -$4.85M |
|
515
Carrier Global
CARR
$52.2B
| $88.8M | 0.01% |
2,152,726
+958,516
| +80% | +$38.9M |
|
516
Bio-Techne
TECH
$11.2B
| $88.6M | 0.01% |
1,069,311
-90,949
| -8% | -$7.22M |
|
517
Raymond James Financial
RJF
$34.8B
| $88.2M | 0.01% |
825,360
-16,779
| -2% | -$1.88M |
|
518
Truist Financial
TFC
$64.7B
| $87.8M | 0.01% |
2,040,320
-29,840
| -1% | -$1.31M |
|
519
Revolution Medicines
RVMD
$43.3B
| $87.7M | 0.01% |
3,680,042
+27,414
| +0.8% | +$583K |
|
520
Sphere Entertainment
SPHR
$6.33B
| $86.6M | 0.01% |
1,926,339
+379,100
| +25% | +$17.2M |
|
521
Factset
FDS
$10.2B
| $85.1M | 0.01% |
212,127
+1,497
| +0.7% | +$638K |
|
522
The Ensign Group
ENSG
$10.6B
| $85M | 0.01% |
898,539
+5,656
| +0.6% | +$513K |
|
523
Credicorp
BAP
$29.8B
| $84.9M | 0.01% |
626,096
+99,303
| +19% | +$14.1M |
|
524
IQVIA
IQV
$39.8B
| $84.5M | 0.01% |
412,514
-10,175
| -2% | -$2.06M |
|
525
Enbridge
ENB
$112B
| $84.5M | 0.01% |
2,160,771
+73,657
| +4% | +$2.88M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.